The analysts following Tilray expect it to perhaps double its 2021 revenues in fiscal 2022. That means that it is possible for Tilray to reach $4 billion in 2024 if its trajectory continues as it has. In other words, it doubles in 2022 to reach $1 billion in revenue.Jan 4, 2022
What are analysts saying about Tilray stock?
Stock Price Forecast The 17 analysts offering 12-month price forecasts for Tilray Brands Inc have a median target of 8.00, with a high estimate of 23.00 and a low estimate of 0.82. The median estimate represents a +46.52% increase from the last price of 5.46.
Is Tilray a buy now?
Shares of Tilray are not in a base or in buy range. So TLRY stock is not a buy right now. IBD advises investors to focus on stocks with stronger fundamentals that are moving into buy zones. Stocks To Buy: Is It Time To Buy Or Sell These Large-Cap Stocks?2 days ago
Why is TLRY stock dropping?
Shares of Tilray were down after the company reported a wider-than-expected net loss in the fourth quarter despite a beat in revenue.
Does Tilray stock pay dividends?
Tilray Brands (NASDAQ: TLRY) does not pay a dividend.
What sector is TLRY in?
Label Value
---------------- ------------------------------------------
Sector Health Care
Industry Biotechnology: Pharmaceutical Preparations
1 Year Target $11.00
Today's High/Low $5.52/$5.15